This contrasted with ccGAS knockdown inhibiting cancer cell growth in vitro, suggesting cGAS deficiency may promote in vivo tumour growth by relieving anti-tumourigenic effects through the cGAS–STING pathway. The gene discussed is STING1; the disease is neoplasm.